The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124755253 12475525 3 F 20160513 20160628 20160617 20160712 EXP PL-TAKEDA-2016MPI005585 TAKEDA 79.00 YR M Y 72.00000 KG 20160712 MD PL PL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124755253 12475525 1 PS VELCADE BORTEZOMIB 1 Subcutaneous 2.34 MG, 2/WEEK 4372089 21602 2.34 MG INJECTION BIW
124755253 12475525 2 SS PREDNISONE. PREDNISONE 1 Oral 110 MG, UNK 4370217;4371050 0 110 MG
124755253 12475525 3 SS DARATUMUMAB DARATUMUMAB 1 Intravenous (not otherwise specified) 1152 MG, 1/WEEK 4371371 0 1152 MG /wk
124755253 12475525 4 SS MELPHALAN MELPHALAN 1 Oral 16 MG, UNK 4372014;4372014 0 16 MG
124755253 12475525 5 C ESCIN ESCIN 1 Oral 20 MG, QD 0 20 MG CAPSULE QD
124755253 12475525 6 C GLIBENCLAMIDE GLYBURIDE 1 Oral 0.5 MG, QD 0 .5 MG CAPSULE QD
124755253 12475525 7 C GLUCOPHAGE METFORMIN HYDROCHLORIDE 1 Oral 1000 MG, QD 0 1000 MG CAPSULE QD
124755253 12475525 8 C RAMIPRIL. RAMIPRIL 1 Oral 5 MG, QD 0 5 MG CAPSULE QD
124755253 12475525 9 C POLOCARD ASPIRIN 1 Oral 75 MG, QD 0 75 MG CAPSULE QD
124755253 12475525 10 C ATORVASTEROL ATORVASTATIN 1 Oral 20 MG, QD 0 20 MG CAPSULE QD
124755253 12475525 11 C VEGEVIT 2 Oral 5 ?G, BID 0 5 UG CAPSULE BID
124755253 12475525 12 C HEVIRAN /00587301/ 2 Oral 800 MG, BID 0 800 MG CAPSULE BID
124755253 12475525 13 C BISEPTOL SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 60 MG, QID 0 60 MG CAPSULE QID
124755253 12475525 14 C FUROSEMIDE. FUROSEMIDE 1 Oral 40 MG, QD 0 40 MG CAPSULE QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124755253 12475525 1 Plasma cell myeloma
124755253 12475525 2 Plasma cell myeloma
124755253 12475525 3 Plasma cell myeloma
124755253 12475525 4 Plasma cell myeloma
124755253 12475525 5 Varicose vein
124755253 12475525 6 Type 2 diabetes mellitus
124755253 12475525 7 Type 2 diabetes mellitus
124755253 12475525 8 Hypertension
124755253 12475525 9 Atherosclerosis prophylaxis
124755253 12475525 10 Hyperlipidaemia
124755253 12475525 11 Prophylaxis
124755253 12475525 12 Prophylaxis
124755253 12475525 13 Antifungal prophylaxis
124755253 12475525 14 Hypertension

Outcome of event

Event ID CASEID OUTC COD
124755253 12475525 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
124755253 12475525 Anaemia
124755253 12475525 Hyperglycaemia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124755253 12475525 1 20160510 0
124755253 12475525 2 20160511 20160513 0
124755253 12475525 3 20160510 20160531 0
124755253 12475525 4 20160510 20160513 0
124755253 12475525 5 2014 0
124755253 12475525 6 2008 0
124755253 12475525 7 2008 0
124755253 12475525 8 2008 0
124755253 12475525 9 2014 0
124755253 12475525 10 2014 0
124755253 12475525 11 20160510 0
124755253 12475525 12 20160510 0
124755253 12475525 13 20160510 0
124755253 12475525 14 20160510 0